Literature DB >> 16431889

Rituximab-induced long-term remission of membranous lupus nephritis.

Stefan H Jacobson, Ronald van Vollenhoven, Iva Gunnarsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16431889     DOI： 10.1093/ndt/gfk068

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

Review 1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

2.  Long-term efficacy of anti-CD20 antibodies in refractory lupus nephritis.

Authors:  C Alejandro Arce-Salinas; Felipe Rodríguez-García; J Iván Gómez-Vargas
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

Review 3.  Rituximab therapy for membranous nephropathy: a systematic review.

Authors:  Andrew S Bomback; Vimal K Derebail; Julie G McGregor; Abhijit V Kshirsagar; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-11       Impact factor: 8.237

Review 4.  [Anti-B-cell strategies in vasculitides and collagenoses].

Authors:  A Rubbert-Roth
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.